3284 related articles for article (PubMed ID: 26467189)
21. Utility of three novel insulin resistance-related lipid indices for predicting type 2 diabetes mellitus among people with normal fasting glucose in rural China.
Wang B; Zhang M; Liu Y; Sun X; Zhang L; Wang C; Li L; Ren Y; Han C; Zhao Y; Zhou J; Pang C; Yin L; Feng T; Zhao J; Hu D
J Diabetes; 2018 Aug; 10(8):641-652. PubMed ID: 29322661
[TBL] [Abstract][Full Text] [Related]
22. Triglyceride Glucose-Body Mass Index Is a Simple and Clinically Useful Surrogate Marker for Insulin Resistance in Nondiabetic Individuals.
Er LK; Wu S; Chou HH; Hsu LA; Teng MS; Sun YC; Ko YL
PLoS One; 2016; 11(3):e0149731. PubMed ID: 26930652
[TBL] [Abstract][Full Text] [Related]
23. Visceral adiposity index and lipid accumulation product as a predictor of type 2 diabetes mellitus: The Bogor cohort study of non-communicable diseases risk factors.
Nusrianto R; Ayundini G; Kristanti M; Astrella C; Amalina N; Muhadi ; Riyadina W; Tahapary DL; Soewondo P
Diabetes Res Clin Pract; 2019 Sep; 155():107798. PubMed ID: 31330161
[TBL] [Abstract][Full Text] [Related]
24. Relationship of metabolic variables to abdominal adiposity measured by different anthropometric measurements and dual-energy X-ray absorptiometry in obese middle-aged women.
Rissanen P; Hämäläinen P; Vanninen E; Tenhunen-Eskelinen M; Uusitupa M
Int J Obes Relat Metab Disord; 1997 May; 21(5):367-71. PubMed ID: 9152738
[TBL] [Abstract][Full Text] [Related]
25. The role of multicomponent therapy in the metabolic syndrome, inflammation and cardiovascular risk in obese adolescents.
Masquio DC; de Piano A; Campos RM; Sanches PL; Carnier J; Corgosinho FC; Netto BD; Carvalho-Ferreira JP; Oyama LM; Nascimento CM; de Mello MT; Tufik S; Dâmaso AR
Br J Nutr; 2015 Jun; 113(12):1920-30. PubMed ID: 25907896
[TBL] [Abstract][Full Text] [Related]
26. Visceral Adiposity Index: A Simple Tool For Assessing Risk Of Type 2 Diabetes Mellitus.
Zar A; Ali SS
J Ayub Med Coll Abbottabad; 2022; 34(2):345-350. PubMed ID: 35576300
[TBL] [Abstract][Full Text] [Related]
27. Lipid Accumulation Product (LAP) and Visceral Adiposity Index (VAI) as Markers of Insulin Resistance and Metabolic Associated Disturbances in Young Argentine Women with Polycystic Ovary Syndrome.
Abruzzese GA; Cerrrone GE; Gamez JM; Graffigna MN; Belli S; Lioy G; Mormandi E; Otero P; Levalle OA; Motta AB
Horm Metab Res; 2017 Jan; 49(1):23-29. PubMed ID: 27571188
[TBL] [Abstract][Full Text] [Related]
28. Sensitivity of various adiposity indices in identifying cardiometabolic diseases in Arab adults.
Al-Daghri NM; Al-Attas OS; Wani K; Alnaami AM; Sabico S; Al-Ajlan A; Chrousos GP; Alokail MS
Cardiovasc Diabetol; 2015 Aug; 14():101. PubMed ID: 26249167
[TBL] [Abstract][Full Text] [Related]
29. Associations between traditional and non-traditional anthropometric indices and cardiometabolic risk factors among inpatients with type 2 diabetes mellitus: a cross-sectional study.
Golabi S; Ajloo S; Maghsoudi F; Adelipour M; Naghashpour M
J Int Med Res; 2021 Oct; 49(10):3000605211049960. PubMed ID: 34657502
[TBL] [Abstract][Full Text] [Related]
30. Hypertriglyceridemia is a practical biomarker of metabolic syndrome in individuals with abdominal obesity.
Li Z; Deng ML; Tseng CH; Heber D
Metab Syndr Relat Disord; 2013 Apr; 11(2):87-91. PubMed ID: 23259588
[TBL] [Abstract][Full Text] [Related]
31. Adiposity measurements in association with metabolic syndrome in older men have different clinical implications.
Hsu CH; Lin JD; Hsieh CH; Lau SC; Chiang WY; Chen YL; Pei D; Chang JB
Nutr Res; 2014 Mar; 34(3):219-25. PubMed ID: 24655488
[TBL] [Abstract][Full Text] [Related]
32. Anthropometric indicators as predictors of total body fat and cardiometabolic risk factors in Chilean children at 4, 7 and 10 years of age.
Vásquez FD; Corvalán CL; Uauy RE; Kain JA
Eur J Clin Nutr; 2017 Apr; 71(4):536-543. PubMed ID: 27827399
[TBL] [Abstract][Full Text] [Related]
33. Plasma adiponectin level is inversely correlated with albuminuria in overweight and obese nondiabetic individuals.
Meyvis K; Verrijken A; Wouters K; Van Gaal L
Metabolism; 2013 Nov; 62(11):1570-6. PubMed ID: 23911242
[TBL] [Abstract][Full Text] [Related]
34. Expression of 11β-hydroxysteroid dehydrogenase type 1 in visceral and subcutaneous adipose tissues of patients with polycystic ovary syndrome is associated with adiposity.
Mlinar B; Marc J; Jensterle M; Bokal EV; Jerin A; Pfeifer M
J Steroid Biochem Mol Biol; 2011 Feb; 123(3-5):127-32. PubMed ID: 21147223
[TBL] [Abstract][Full Text] [Related]
35. Lipid levels in obese and nonobese subjects as predictors of fasting and postload glucose metabolism.
Giannini S; Bardini G; Dicembrini I; Monami M; Rotella CM; Mannucci E
J Clin Lipidol; 2012; 6(2):132-8. PubMed ID: 22385546
[TBL] [Abstract][Full Text] [Related]
36. Waist-to-height ratio, waist circumference and BMI as indicators of percentage fat mass and cardiometabolic risk factors in children aged 3-7 years.
Sijtsma A; Bocca G; L'abée C; Liem ET; Sauer PJ; Corpeleijn E
Clin Nutr; 2014 Apr; 33(2):311-5. PubMed ID: 23768783
[TBL] [Abstract][Full Text] [Related]
37. Sex differences in fat distribution influence the association between BMI and arterial stiffness.
van den Munckhof ICL; Holewijn S; de Graaf J; Rutten JHW
J Hypertens; 2017 Jun; 35(6):1219-1225. PubMed ID: 28441693
[TBL] [Abstract][Full Text] [Related]
38. Visceral adiposity index levels in overweight and/or obese, and non-obese patients with polycystic ovary syndrome and its relationship with metabolic and inflammatory parameters.
Durmus U; Duran C; Ecirli S
J Endocrinol Invest; 2017 May; 40(5):487-497. PubMed ID: 27838846
[TBL] [Abstract][Full Text] [Related]
39. Importance of Measured Body Fat, Visceral Adiposity Index, and Lipid Accumulation Product Index in Predicting Cardiometabolic Risk Factors.
Demirbas N; Kutlu R
Metab Syndr Relat Disord; 2021 Apr; 19(3):174-179. PubMed ID: 33121374
[No Abstract] [Full Text] [Related]
40. Triglycerides and waist to height ratio are more accurate than visceral adiposity and body adiposity index to predict impaired fasting glucose.
Elizalde-Barrera CI; Rubio-Guerra AF; Lozano-Nuevo JJ; Olvera-Gomez JL
Diabetes Res Clin Pract; 2019 Jul; 153():49-54. PubMed ID: 31132383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
